OR WAIT null SECS
Rita Peters is editorial director of Pharmaceutical Technology, Pharmaceutical Technology Europe, and BioPharm International.
Thought leaders tackle drug shortages and manufacturing innovations.
At INTERPHEX 2016 at the Javits Center in New York, Pharmaceutical Technology will host a Keynote Series on leading bio/pharma industry issues. Sessions will be presented on the Innovation Stage in the exhibit hall. Admission is free to any attendee with an exhibit hall pass. The following is a preview of the topics.
Overcoming Bottlenecks in Biopharmaceutical Development
(Tuesday, April 26, 10:15-11:45 am)
Industry experts discuss how technology advances are addressing challenges in biopharmaceutical development.
Innovations in Solid Dosage Development and Manufacturing
(Tuesday, April 26, 1-3:30 pm)
Drop-On-Demand Manufacturing System for the Flexible Production of Solid Oral Dosage Forms.
Dropwise additive manufacturing of pharmaceutical products uses drop-on-demand printing for automated and controlled deposition of solution-, melt-, or suspension-based formulations onto edible substrates.
Polymer Thin Films for Drug Delivery: Process and PAT Development.
Polymer thin film is a platform technology for continuous manufacturing, in which in-line monitoring of product quality can be accomplished using various sensing and process analytical technologies, making the technology amenable for real-time release.
Minitablets: Manufacturing, Characterization Methods, and Future Opportunities.
Manufacturing techniques used to produce minitablet-based dosage forms are essentially the same as manufacturing of larger tablet images; however, some special considerations to manufacturing techniques and analytical tests may be required.
Contract Services Market: 2016 Update
(Wednesday, April 27, 10:30-11:30 am)
How will consolidation in the bio/pharmaceutical and contract services market, a changing financial market, and an active political and regulatory year shape the fortunes of the contract services market? In his annual presentation, Jim Miller, founder and president of PharmSource Information Services, will offer his perspectives on the contract services landscape for the next few years.
Strategies and Innovations to Reduce Drug Shortages and Improve Availability of Medicines
(Wednesday, April 27, 1:30-3:15 pm)
An Interdisciplinary Approach to Address Drug Shortages. The effects of drug shortages on patients, caregivers, hospitals, and medical professionals are often not observed or understood by the bio/pharmaceutical manufacturing segment. This presentation will explore alternative, innovative, and cost-effective ways to provide needed therapies to patients.
BARDA Innovation Initiatives in Medical Countermeasure Manufacturing. This presentation will describe the Biomedical Advanced Research and Development Authority’s (BARDA) program initiatives in manufacturing technologies for medical countermeasure advanced development, including opportunities with the Centers for Innovation in Advanced Development & Manufacturing and in continuous manufacturing.
Continuous Manufacturing for Rapid Process Development. The pharmaceutical industry has begun to adopt continuous manufacturing technology for the manufacture of traditional solid-dosage forms. Benefits include lower cost and expedited development due to the ability to develop at scale. This presentation will outline some of the new approaches and potential benefits.
Panel Discussion: Addressing Sterile Manufacturing Challenges
(Wednesday, April 27, 3:30-4:30 pm)
Sterile injectables have been in extremely short supply, and industry efforts have been focusing on root causes involving infrastructure, quality, and efficiency. Experts involved in this work discuss recent initiatives, and offer insights into what must be done to prevent injectables shortages in the future.
For more information about the Keynote Series, visit: www.PharmTech.com/pt/Interphex2016.
Vol. 40, No. 3
When referring to this article, please cite it as R. Peters, " Keynote Series Addresses Crucial Industry Issues," Pharmaceutical Technology 40 (3) 2016.